Cardio Diagnostics Holdings, Inc. Recapitalization Costs
Cardio Diagnostics Holdings, Inc. (CDIO) reported Recapitalization Costs of $1.54 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RecapitalizationCosts · last filed 2025-03-20
- Cardio Diagnostics Holdings, Inc. recapitalization costs for the quarter ending 2024-12-31 was $0.00.
- Cardio Diagnostics Holdings, Inc. recapitalization costs for the quarter ending 2024-09-30 was $0.00.
- Cardio Diagnostics Holdings, Inc. recapitalization costs for the quarter ending 2024-06-30 was $0.00.
- Cardio Diagnostics Holdings, Inc. recapitalization costs for the quarter ending 2024-03-31 was $1.54M, a 0.00% change year-over-year.
- Cardio Diagnostics Holdings, Inc. recapitalization costs for fiscal 2024 was $1.54M, a 0.00% change from fiscal 2023.
- Cardio Diagnostics Holdings, Inc. recapitalization costs for fiscal 2023 was $1.54M, a 0.00% change from fiscal 2022.
- Cardio Diagnostics Holdings, Inc. recapitalization costs for fiscal 2022 was $1.54M.
| Period end | Recapitalization Costs 3 month | Recapitalization Costs 6 month | Recapitalization Costs 9 month | Recapitalization Costs 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | $1.54M 10-K · filed 2025-03-20 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $1.54M 10-Q · filed 2024-11-13 | $1.54M derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $1.54M 10-Q · filed 2024-08-12 | $1.54M derived: sum of 3 quarters · filed 2024-08-12 | $1.54M derived: sum of 4 quarters · filed 2024-08-12 |
| 2024-03-31 | $1.54M 10-Q · filed 2024-05-15 | $1.54M derived: sum of 2 quarters · filed 2024-05-15 | $1.54M derived: sum of 3 quarters · filed 2024-05-15 | $1.54M derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $0.00 derived: sum of 3 quarters · filed 2024-04-01 | $1.54M 10-K · filed 2024-04-01 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $1.54M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.54M 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | $1.54M 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | $1.54M 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |